HopeStage
Back to all studies
CompletedNCT01161277

Aripiprazole and Haloperidol Effects on Brain Activity

About this titleRead the official source — NCT01161277
Medication studyAges 18–50NorwaySchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 50 years.

Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2010
Recruitment status
Completed
Enrollment listed in the registry
54
Sponsor
Oslo University Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Norway
Age range
From 18 Years to 50 Years
Official registry ID
NCT01161277
Official title
Show the full official title

Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning: A Pharmacological fMRI Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Oslo

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Oslo University Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Aripiprazole, Haloperidol and Placebo sugar pill.

Who was this study for?

Listed age limits: 18 years to 50 years.

Want to explore more studies?

Explore studies